CrushSCI.com
233平均天数
225.5中位天数
102最短天数
408最长天数
1302025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

408 天

Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer

作者
Xin Ouyang; Xiaotong Deng; Qizhao Wang; Minghui Chu; Xinyu Wei; Mengting Wang; Chunming Xiang; Peng Zhang; Zhe Sun; Shijun Shen; Yao Xu展开收起
作者单位
1. Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, China; 2. Department of Hepatopancreatobiliary and Minimally Invasive Surgery, the People’s Hospital of Lincang, Lincang, China; 3. Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China; 4. College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China; 5. College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan, China展开收起
PDF源文件 DOI 网页
232 天

LncRNA PCAT7 drives tumorigenesis and glycolytic reprogramming in breast cancer via the ceRNA-mediated miR-204-5p/RUNX2 axis

作者
Pengxiang Zhu; Wei Wu; Yining Han; Zhihan Yao; Rongxuan Xu; Xiaofeng Li展开收起
作者单位
1. Department of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China展开收起
PDF源文件 DOI 网页
288 天

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability

作者
Rohit Sivaprasad; Kristijonas Žemaitis; David Linfeldt; Sudip Ghosh; Anne de Snaijer; Mattias Magnusson; Fredrik Ek; Jenny Hansson; Agatheeswaran Subramaniam展开收起
作者单位
1. Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden; 2. Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden; 3. Chemical Biology & Therapeutics, Lund University, Lund, Sweden展开收起
PDF源文件 DOI 网页
139 天

CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination

作者
Jing Shen; Wen Zhang; Zhiqiang Chu; Lei Zhu; Yan Feng; Xuling Sun展开收起
作者单位
1. Department of Scientific Research, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 2. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 3. Department of Gastroenterology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China; 4. Xinjiang Clinical Research Center for Digestive Diseases, Urumqi, PR China展开收起
PDF源文件 DOI 网页
219 天

HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway

作者
Jing Zhang; Qionghui Wu; Jingyuan Liu; Shisheng Li展开收起
作者单位
1. Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 3. Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, China; 4. Department of Otorhinolaryngology, Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha, China展开收起
PDF源文件 DOI 网页
184 天

Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies

作者
Na Li; Shurong Li; Peng Cao; Mengfan Tang; Junfeng Zhang; Wei Zhang; Jinfeng Liu; Chunping Ye; Dan Wu; Xixi Li; Li Dai; Xianglin Zuo展开收起
作者单位
1. Department of Immunology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; 3. Department of Obstetrics and Gynecology, Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pathogen Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 5. Department of Basic Medical Sciences, Jiangsu Medical College, Yancheng, China; 6. Biobank of Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。